Company & Sponsor Intelligence

Hospital Universitari Vall d'Hebron Research Institute

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting0

Completed3

Countries1

Therapeutic footprint

adhddementia_otherother_neurologypain_neuropathyparkinsonsstrokesubstance_use

Indexed studies

NCT05395832Effectiveness of Video-based Multicomponent Treatment for Fibromyalgia Plus Face-to-face Sesions in Nature or at Sea
pain_neuropathy · SpainNA

NCT02172183CBT Group for Adolescents With ADHD: a Randomized Controlled Trial
adhd · SpainNA

NCT00437177Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence (ALC-DRD2-APO)
substance_use · SpainPHASE2

NCT05377567Cost-utility and Immuno-inflammatory Effects of the FIBROWALK in Patients With Fibromyalgia (the On&Out Study)
pain_neuropathy · SpainNA

NCT03602924Long-term Safety and Effectiveness of Levodopa-carbidopa Intestinal Gel Infusion
parkinsons · SpainUNKNOWN

NCT04593225Effectiveness of VIRTUAL SFCAMINA STUDY
other_neurology · SpainNA

NCT01073007Stroke Treatment With Acute Reperfusion and Simvastatin
stroke · SpainPHASE4

NCT04281186Retinal and Cognitive Dysfunction in Type 2 Diabetes
dementia_other · SpainCOMPLETED

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →